Short answer: no. TB-500 is not an FDA-approved drug. It is a synthetic peptide related to thymosin beta-4, supplied strictly as a research-use-only compound, not for human consumption. TB-500 is on the FDA’s July 23, 2026 compounding advisory committee agenda (evaluated use: wound healing) — a review of possible 503A Bulks List inclusion, which is not drug approval. It is also prohibited in tested sport by WADA.
Like its frequent companion BPC-157, TB-500 is widely discussed in recovery and tissue-repair circles — and just as often misunderstood when it comes to its regulatory status. The short answer to “is TB-500 FDA approved?” is no. Here is the fuller picture, including the July 2026 FDA review and the sport-doping angle.
FDA approval requires a sponsor to submit a New Drug Application backed by Phase I–III clinical trials, manufacturing controls and a characterised safety profile, after which the FDA decides whether the drug is safe and effective for a specific indication. TB-500 has not been through that process — there is no approved application and no completed Phase III programme. For the compounds that have cleared that bar, see our FDA peptide approval pipeline guide.
No. TB-500 is a synthetic peptide associated with the active region of thymosin beta-4, a naturally occurring protein studied in cellular-migration, angiogenesis and wound-healing research. The two names are often used interchangeably in research discussion, though they are not strictly identical. As of 2026, TB-500 remains a research compound: supplied to laboratories as a reagent, labelled research use only, not for human consumption.
The usual confusion. “Not FDA approved” does not mean “banned” or “illegal to study.” It means TB-500 has not been authorised as a medicine for human use. Research-grade material is a separate category, and the legal line follows marketing and use, not the molecule alone.
On July 23, 2026, the FDA’s Pharmacy Compounding Advisory Committee is scheduled to discuss TB-500 bulk drug substances (free base and acetate), with wound healing listed as the evaluated use, as part of a review of several peptide-related substances for potential 503A Bulks List inclusion. The 503A list relates to traditional pharmacy compounding — not mass-market drug approval. A recommendation for inclusion would not make TB-500 an FDA-approved medicine. We cover the regenerative angle in detail in our BPC-157 and TB-500 FDA review.
Yes. The World Anti-Doping Agency (WADA) prohibits TB-500 and thymosin beta-4 at all times. Any athlete in a tested sport who uses it risks an anti-doping violation, independent of the compound’s research-use status. If you compete under WADA or a national anti-doping code, treat TB-500 as prohibited. (BPC-157 carries the same WADA prohibition — see Is BPC-157 banned?)
As with BPC-157, most of the TB-500 / thymosin beta-4 evidence base is pre-clinical rather than the large, controlled human trials approval demands. It is also a peptide with limited commercial-trial sponsorship, and regulators have raised characterisation and safety-data questions. That reflects where the formal evidence process stands, not a verdict on the underlying biology.
Because TB-500 is not approved, responsible suppliers position it for laboratory research use only, not for human consumption, and back it with batch-specific testing. Look for a Certificate of Analysis confirming identity and purity, and treat any “FDA-approved TB-500” claim as a red flag — no such approval exists.
Is TB-500 FDA approved?
No. It is not an FDA-approved drug; it is a research-use-only peptide related to thymosin beta-4, not for human consumption.
Is TB-500 the same as thymosin beta-4?
Closely related and often used interchangeably, but not strictly identical. Neither is FDA approved.
Is TB-500 banned in sport?
Yes — WADA prohibits TB-500 and thymosin beta-4 at all times for tested athletes.
Source: the FDA’s July 23–24, 2026 Pharmacy Compounding Advisory Committee meeting agenda, and the WADA Prohibited List. External links are provided for research reference only; New-U is not affiliated with these organisations and links carry no endorsement either way.
New-U Research Compounds supplies sealed 10-vial packs, independently verified by Janoshik and Freedom Diagnostics for >99% purity, with a Certificate of Analysis. Research use only - not for human consumption.
Browse the catalogAt New-U, we believe better conversations start with better information. For laboratory research use only. Not for human consumption.